Global Alliance for Vaccines and Immunization. n An Alliance u Traditional and new partners u Public and private sector n Partners have in common: u Situation.


Similar presentations
Coordination for Children and HIV and AIDS in East Asian Pacific Region - Inter-Agency Mechanisms.

Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Synergies between the GAVI Alliance and health systems strengthening Dr. Craig Burgess, GAVI Secretariat 29 May 2008.
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
GIM meeting Feb |1 | Global Action Plan for Prevention and Control of Pneumonia (GAPP) and progress S. Qazi and T Cherian On behalf of the GAPP.
THE INTERNATIONAL DRUG PURCHASE FACILITY-UNITAID Michel D. Kazatchkine, Ministère des Affaires Etrangères, France.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Universal Coverage – Can we guarantee health for all? 3 – 4 October 2011, Kuala Lumpur Nossal perspective.
World Bank Financial Management Sector September 2010.
Santiago Cornejo GAVI HSS and Future Joint Programming with the World Bank and the Global Fund to fight AIDS, TB and Malaria Cusco, 10 November 2009.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
AIDS AND THE PRIVATE SECTOR Lessons from the Asia Pacific’
Global Alliance for Vaccines and Immunization. WHAT IS GAVI ?
Critical conversations in Public-private partnerships Dr Ranjana Kumar 1 st November 2007.
Advance Market Commitments for Vaccines Carlo Monticelli International Financial Relations Ministero dell’Economia e delle Finanze.
Working Together to Improve Global Health
1 European Region Global Alliance for Vaccines & Immunization Overview on the Implementation Of the Introduction of New / Under-used Vaccines.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Post-2015 Development Agenda Emerging Cross-Cutting Themes December 5, 2013.
AusAID’s approach to health in developing countries
1 Collective Efficiencies Development Finance Architecture Workshop Prerna Banati - July
The partners,initiatives, alliances, groups and meetings within world of the Expanded Programme on Immunization Quick overview 25-September-2012 GID presentation.
Multilateral Mechanisms for Managing International Development Assistance. The Challenge of Effectiveness and Reform Yuriy Zaytsev National Research University.
The Implications of Different Governance Models for Multi-stakeholder partnerships Jennifer Adams, USAID 19 November 2013.
Civil Society in Decision Making for Immunization Policies: the example of National Immunization Technical Advisory Groups (NITAGs) Center for Vaccine.
Effective ways to reach smallholders Value chain financing 18th October 2007 By George Odo The CARE Africa Venture Fund care australia care thailand care.
11 Bill & Melinda Gates Foundation Global Libraries Initiative April 2007.
Partnerships in Promoting Innovation and Managing Risk Scientific and Financial Innovation in AIDS Vaccines International AIDS Vaccine Initiative Labeeb.
Sources of Support and What They Mean to the Field Dr. Duff Gillespie June 15 th, 2002 Africa SOTA, Nairobi.
The Global Fund- structure, function and evolution February 18, 2008.
 Berlin Civil Society Centre PricewaterhouseCoopers November 2009 Connected thinking in development.
Infrastructure Consortium Meeting June IFF for Immunziation Andrew Jones Senior Programme Officer, Innovative Financing.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
Keeping promises, Measuring results: The Global Strategy and Accountability for Women's and Children's Health Bernadette Daelmans Family, Women and Children's.
GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.
Ibero-American Road Safety Conference Madrid, February 23-24, World Bank Global Road Safety Facility.
16 th March th March 2009 Ministry of Foreign Affairs of Japan 16 th March th March 2009 Ministry of Foreign Affairs of Japan Japan’s Policy.
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
What is HMN? Global partnership founded on the premise that better health information means better decisions and better health Partners reflect wide.
Presenter Name Date. Who We Are Global partnership founded on the premise that better health information means better decisions and better health Partners.
Embassy of Sweden, Lusaka Working together for greater impact: Sweden’s collaboration with the Southern African Development Community (SADC) Francis Mangani.
The Global Fund and Southern Africa A review of the structures and grants in southern Africa.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
AMC Governance and Institutional Support. Objectives Build on existing capacity Ensure appropriate independence and credibility through transparency,
Agricultural Finance Support Facility An Initiative to Jump-start Agricultural and Rural Finance through Institutional Capacity Building A partnership.
Roles of the International Task Force on Teachers for Education for All (EFA) for Teacher Motivation Working Group Workshop, CIES March 2015 Hiromichi.
T h e A A A H Asia-Pacific Action Alliance on Human Resources for Health.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Global Fund Grants To SOTA Countries NO YR1 ALL Yrs TIER 113 $91 mil $461mil TIER 22 (5) $70 mil $443 mil _________________________________________________________________________.
Country HIS assessments Interim report July th Board Meeting July, 2007 Seattle, U.S.A.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
Interagency Pharmaceutical Coordination Group Hitesh Hurkchand RMNCH Strategy and Coordination Team Liliane Kandeh and her son picking up their malaria.
Injection Safety in the Context of and. “The only thing standing in the way of saving millions of additional kids is ensuring an adequate supply of vaccines.
Elaine Ireland Global Health Advocacy Officer, International HIV/AIDS Alliance Rome, 9 th February Delivering Effective Aid for Health: International Health.
GAVI, IFFIm & Vaccine Bonds Overview International Finance ’14 Michelle Han 132SIS48.
BASIC FACTS ABOUT GAVI, THE VACCINE ALLIANCE Page: 1 #vaccineswork Gavi/2012/Doune Porter.
Fifteenth Board Meeting Geneva, April 2007 Partners in Impact Results Report Global Fund Board Meeting Geneva, April 2007.
“Global Health and Financing for Development” Action for Global Health Conference Rome, 09 th February, 2009 Dr. Aida Libombo MD, Obstetrician/Gynaecologist,
GFF Third Investors Group Meeting Geneva, Switzerland June 23-24, 2016 Financing for RMNCAH: complementary financing Global Fund’s engagement with the.
The HIV Response Where are we now?
Outline The Global Fund Strategy emphasizes the Key Populations
Presentation transcript:

Global Alliance for Vaccines and Immunization

n An Alliance u Traditional and new partners u Public and private sector n Partners have in common: u Situation Analysis u Vision u Set of strategic objectives What is GAVI ?

Three Gaps in Vaccines and Immunization +Stagnation of immunization coverage with decline in certain countries and regional discrepancies + Lack of introduction into the poorer developing countries of newly-developed vaccines against major child killers + Limited investment into vaccine research for diseases with high burden in developing countries

GAVI Mission To save childrens lives and protect peoples health through the widespread use of vaccines with a particular emphasis on developing countries

Five Strategic Objectives +Improve access to sustainable immunization services +Expand use of all existing cost-effective vaccines +Accelerate introduction of new vaccines +Accelerate R&D on vaccines for developing countries, (HIV/AIDS, malaria and tuberculosis) +Make immunization coverage a centrepiece in international development efforts

n Countries (Developing and industrialised) n Agencies (UNICEF, WHO) n Development Banks (World Bank, ADB, AB) n Industry n Technical Agencies (CDC, NIH) n Foundations (Bill and Melinda Gates, Rockefeller, Mérieux...) n NGOs (Path/CVP, AMP...) n Academia WHO is GAVI?

GAVI Board 15 members High-Level : Institutional Commitment Working Group Secretariat Monthly Tele/Video Conferences 3 meetings per year Weekly Tele/Video Conferences 5-6 Meetings per year 10 members Joint policy development, Agency workplans Small team, Funded by partner fees Coordination Support coordination of partners input How Does GAVI Work ?

Task Forces : u Advocacy (UNICEF) u Country Coordination (WHO) u Financing (World Bank and USAID) u R&D (Academia, Industry, WHO) Regional Working Groups u Africa, East Asia -Pacific, South Asia, Middle East and ….

Strengthened Immunization Services and New Vaccines Delivered in Countries Vaccine procurement The Fund Independent Board for fundraising & management Working Capital Account (at UNICEF) for vaccine procurement and resource disbursement Three Sub-accounts: Financial Tools: Shares, matching grants Vaccines & Safe injection materials Immunization services R & D (not yet active) GAVI Board Establishes Principles recommendations on fund allocation Contributors Gates Foundation USA, UK, Norway, Netherlands,... $$$ The Global Fund For Childrens Vaccines

Requirements for GFCV Support n Eligibility u Countries with < US$ 1,000 GNP / capita u Special arrangements foreseen for China, India and Indonesia n Assessment Criteria u Functioning collaborative mechanism (e.g., ICC) u Immunization assessment within last three years u Multi-year plan for immunization

Support for new and under-used vaccines Support for immunization services and new and under-used vaccines Support for immunization services DTP3 coverage >80% DTP3 coverage 50% - 80% DTP3 coverage <50% Basic Conditions GNP/capita < US$ 1000 ICC or equivalent Immunization assessment in last 3 years Multi-year plan for immunization What will the FUND Finance ?

New and Under-used Vaccines n Hepatitis B globally n Hib vaccine for Africa, Latin America, Middle East & where evidence exists n Yellow fever where recommended in Africa & South America u even when DTP3<50% n Safe injection equipment: u auto-disable syringes and safety boxes bundled with vaccine shipped to countries n Combination vaccines u priority to weakest programmes

Immunization Services Add to pool of existing funding Invest in advance, on the basis of set targets for the improvement of the programme Reward progress according to performance Monitor progress by reporting of district performance, according to standard indicators and annual review to ICC, to GAVI partners Delegate allocation of funds through government, partner agency, or other ICC mechanism - no strings, no international input monitoring system.

How are Applications Assessed ? n Independent review committee (10 members) n Tunisia, Ghana, Tanzania, Cameroon, USA, Thailand, Slovenia, Bahamas, Moldova n Majority from developing countries n Strong immunization programme management experience n Meets for 10 days- 2 weeks for in-depth review n Each application reviewed by 3 members n Members declare any conflict of interest n Recommendations to the GAVI Board

Pledges to GAVI Objectives Gates Foundation : US $ 750 million (5 yrs) USA : US $ 50 Million (1 yr ) Norway NKr 1 billion (5 yrs) UK : GB £ 3 million (1 yr) Netherlands : NGL 250 million (5 yrs) Denmark : Dkr 20 million (1yr) Sweden US $ 2 million (1yr) Total Pledges to date : 0ver US $ million

Status of 74 Eligible* Countries * (GNP per capita < US$ 1,000) Commitments through 2002: US $ 16,5 Million for immunization services strengthening US $ 74 Million in new vaccines

Next Milestones Progress report : 1 October 2001 Mid term review : 1 October 2002 Next reviews of applications: n 1 May : Review starting 24 May n November until Spring 2002 * All applications approved before Spring 2002 will result in 5 years support

What is Expected of Countries ? Increased commitment to strengthen immunization u Establish, strengthen and manage an Inter Agency Coordination mechanism u Develop,monitor and update a multi-year plan for immunization including: F Polio eradication F Injection safety F Resource mobilization plan u Negotiate and secure financing from F National Budgets (including loans) F Bilateral and Multi-lateral Partners support F The Global Fund for Childrens vaccines

What are Partners Responsible For? Increased commitment to immunization u Increased coordination of technical and financial support u Procurement of vaccines and goods u Consultants, Funding u Training (technical, management, financing) u Capacity building to develop regional expertise u Networking with other countries to learn from experiences